Organogenesis Holdings Inc.ORGONASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+356.4%
5Y CAGR+53.2%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+356.4%/yr
vs -4.7%/yr prior
5Y CAGR
+53.2%/yr
Recent acceleration
Acceleration
+361.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
8.4x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 4019.43% |
| Q3 2025 | 102.31% |
| Q2 2025 | -54.96% |
| Q1 2025 | -411.00% |
| Q4 2024 | 23.67% |
| Q3 2024 | 114.35% |
| Q2 2024 | 123.08% |
| Q1 2024 | -269.90% |
| Q4 2023 | -32.23% |
| Q3 2023 | 837.75% |
| Q2 2023 | 109.08% |
| Q1 2023 | -342.54% |
| Q4 2022 | 42.29% |
| Q3 2022 | -222.90% |
| Q2 2022 | 176.54% |
| Q1 2022 | -141.36% |
| Q4 2021 | 14.12% |
| Q3 2021 | -16.35% |
| Q2 2021 | 312.98% |
| Q1 2021 | -135.98% |
| Q4 2020 | 475.86% |
| Q3 2020 | 126.25% |
| Q2 2020 | 46.56% |
| Q1 2020 | -118.34% |
| Q4 2019 | -46.54% |
| Q3 2019 | 49.41% |
| Q2 2019 | -34.68% |
| Q1 2019 | 84.04% |
| Q4 2018 | -21480.58% |
| Q3 2018 | -36.47% |
| Q2 2018 | 7.20% |
| Q1 2018 | -146.50% |
| Q4 2017 | 83.11% |
| Q3 2017 | -410.25% |
| Q2 2017 | 238.77% |
| Q1 2017 | 76.51% |
| Q4 2016 | -2096.14% |
| Q3 2016 | -10260.17% |
| Q2 2016 | 200.00% |
| Q1 2016 | 0.00% |